Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C21H27FN2O2 |
| Molecular Weight | 358.4497 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC=C1N2CCN(CCCC(O)C3=CC=C(F)C=C3)CC2
InChI
InChIKey=LCZRXFYSMJIDQQ-UHFFFAOYSA-N
InChI=1S/C21H27FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11,20,25H,4,6,12-16H2,1H3
| Molecular Formula | C21H27FN2O2 |
| Molecular Weight | 358.4497 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Anisopirol is a neuroleptic and was used as antipsychotic drug. Anisopirol, the alcohol resulting from reduction of the carbonyl group of fluanisone, is an exception and is in fact about two times more potent than fluanisone itself. Anisopirol is poorly absorbed by the oral route. Dopamine receptor is known pharmacological target of anisopirol and NMDA receptor is predicted target.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:58:35 GMT 2025
by
admin
on
Mon Mar 31 17:58:35 GMT 2025
|
| Record UNII |
162A01WTAJ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29710
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
167758
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
857-62-5
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
C74174
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
100000086929
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL104515
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
DTXSID20861938
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
162A01WTAJ
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
13333
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
1603
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY | |||
|
SUB05521MIG
Created by
admin on Mon Mar 31 17:58:35 GMT 2025 , Edited by admin on Mon Mar 31 17:58:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
